Marta Padovan
@martapdn.bsky.social
Neuro-oncologist @iov_irccs | PhD in Oncology Immunology @UniPadova | Young Neuro-Oncologist 2024-2027 @EORTC Brain Tumor Group
Reposted by Marta Padovan
🧠 Great exchange at our EANO Youngsters - EORTC Joint session at #EANO2025!
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
October 18, 2025 at 9:53 AM
🧠 Great exchange at our EANO Youngsters - EORTC Joint session at #EANO2025!
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
🚀 We discussed how collaboration through EORTC supports early-career investigators - and vice versa - plus insights into current brain tumor trials.
Thanks @eortc.org & @eanoassociation.bsky.social!
#NeuroOncology #btsm
Reposted by Marta Padovan
🚨 Big news from #EANO2025!
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
October 18, 2025 at 9:58 AM
🚨 Big news from #EANO2025!
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
Final #CATNON results show adding 12 cycles of temozolomide after radiotherapy doubles survival in IDH-mutant anaplastic astrocytoma: 12.5 vs 6 years.
🌍 A global academic effort in rare cancers.
🔗 Full story: www.eortc.org/blog/2025/10...
@eanoassociation.bsky.social
Attending the #EANO2025 Educational Day: an incredible opportunity to learn about the challenging topics we face in neuro-oncology, all from the insightful perspectives of leading experts.
Don't miss the session EDB05 on the blood-brain barrier — North Hall 3.30 pm
Don't miss the session EDB05 on the blood-brain barrier — North Hall 3.30 pm
🎓 The #EANO2025 Educational Day kicks off today in Prague! A full day dedicated to in-depth learning across #NeuroOncology — bringing together experts and trainees in the field.
#btsm #EducationalDay
#btsm #EducationalDay
October 16, 2025 at 9:05 AM
Attending the #EANO2025 Educational Day: an incredible opportunity to learn about the challenging topics we face in neuro-oncology, all from the insightful perspectives of leading experts.
Don't miss the session EDB05 on the blood-brain barrier — North Hall 3.30 pm
Don't miss the session EDB05 on the blood-brain barrier — North Hall 3.30 pm
Reposted by Marta Padovan
📢 @eanoassociation.bsky.social 2025 kicks off today in Prague!
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
October 16, 2025 at 8:32 AM
📢 @eanoassociation.bsky.social 2025 kicks off today in Prague!
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
Proud to see strong #EORTC representation with six abstracts and a joint session with BTG featuring EORTC-led projects on clinical trial planning.
More info 👉 www.eortc.org/blog/2025/10...
#EANO2025 #NeuroOncology @qol.eortc.org
Today I completed my #PhD.
A chapter that had stayed open through intense but also difficult times.
Yet I am grateful, because during this period, little Giacomo came into my life.
Let's move forward.
A chapter that had stayed open through intense but also difficult times.
Yet I am grateful, because during this period, little Giacomo came into my life.
Let's move forward.
July 7, 2025 at 6:53 PM
Today I completed my #PhD.
A chapter that had stayed open through intense but also difficult times.
Yet I am grateful, because during this period, little Giacomo came into my life.
Let's move forward.
A chapter that had stayed open through intense but also difficult times.
Yet I am grateful, because during this period, little Giacomo came into my life.
Let's move forward.